Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Supporters often emphasize the potential for substantial therapeutic gains, especially in conditions where conventional therapies have proven limited. However, crucially important to consider the considerable financial expenditure associated with CPI s